NanoBlood, LLC

NanoBlood, LLC is a health institution located at 2301 East 60th Street North, Sioux Falls, South Dakota, United States. The institution specializes in developing SanFlow, a nano red blood cell, as a substitute for genetic therapy and transfusion therapy in children with sickle cell disease (SCD) to prevent stroke and severe painful vaso-occlusive crisis. The FDA has recognized the potential of SanFlow for critical care and transfusion medicine based on pre-clinical safety and efficacy results.

SanFlow is a ~7 nm nanoparticle with a unique 3D structure designed to prevent vasoconstriction and promote blood flow. The Company is actively seeking strategic partnerships to address the un-met medical needs in major markets such as stroke, traumatic brain injury, and hemorrhagic shock. NanoBlood, LLC recently announced its relocation to the South Dakota Technology Business Center in Sioux Falls to further develop and commercialize its life-saving nano red blood cell drug.

Governor Dennis Daugaard expressed his support for the innovative work being done at NanoBlood, LLC, stating that it is rewriting medical history and saving lives. The SDTBC is excited to be the new corporate location for the institution and looks forward to supporting its development for both domestic and global markets.